MIRM
MIRM
US6047491013
Mirum Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
5.58B EUR
7.58B EUR
5.63B EUR
4.1B EUR
Enterprise Value
5.61B EUR
8.01B EUR
5.63B EUR
4.12B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-248.1x
--
--
--
Price to Sales
9.04x
12.27x
9.88x
10x
Price to Book
--
--
23.21x
13.03x
EV/Revenue
9.07x
12.96x
9.88x
10.06x
EV/EBITDA
-79.78x
--
--
194.38x
Price to FCF (P/FCF)
72.89x
--
--
72.08x
EV/FCF
73.18x
--
--
72.48x
FCF Yield
1.37%
-3.48%
-3.24%
1.39%
ende